Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic
- Status
- COMPLETED
- Phase
- PHASE2
Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
- Status
- UNKNOWN
- Phase
- PHASE3